Not Signed In - Restless Leg Syndrome drug, REQUIP®, approved by FDA
Sat, 07 May 2005 04:00 AM EST
... The US FDA has approved Requip® (ropinirole HCl) Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS) in adults, GlaxoSmithKline announced today... click link for more info. ...
Related Topics
- Restless Legs Syndrome
- Restless Leg Syndrome
- Drug Safety
- Ropinirole
- Hyperthyroidism
- Chronic Fatigue Syndrome
- Irritable Bowel Syndrome
- Prescription Drugs
- Pain - Chronic
- Chronic Pain
- Syndrome X
- Asperger's Syndrome
- Down Syndrome
- Marfan Syndrome
- Tourette Syndrome
- Drug Side Effects
- Metabolic Syndrome
- Turner syndrome
- Williams Syndrome
- Fragile X Syndrome
email this page
print this page
bookmark this page
feedback on this page
